Roles for specialized secretory epithelial cells in inflammatory bowel disease

Area of Science:

• Gastroenterology and Immunology
• Epithelial Biology
• Mucosal Immunology

Background:

• Current inflammatory bowel disease (IBD) treatments primarily target immune pathways, but many patients do not achieve lasting remission.
• This highlights the need to investigate epithelial-intrinsic factors contributing to chronic inflammation and impaired gut barrier function.
• Recent research redefines secretory epithelial cells as key regulators of mucosal immunity, microbial defense, and tissue repair.

Purpose of the Study:

• To explore the role of secretory epithelial lineages in regulating mucosal immunity and barrier integrity during chronic inflammation.
• To understand how region-specific programs in epithelial cells change during inflammatory conditions.
• To identify potential epithelial-targeted therapeutic strategies for IBD.

Main Methods:

• Review of recent single-cell, spatial, and functional studies.
• Analysis of secretory epithelial cell heterogeneity and function.
• Investigation of region-specific alterations in goblet, tuft, and Paneth cells.

Main Results:

• Goblet cells act as heterogeneous sentinels, with alterations influencing IBD location and variability.
• Tuft cells function as chemosensory hubs, linking luminal signals to neuroimmune responses and promoting repair.
• Paneth cell dysfunction is observed in Crohn's disease, while ulcerative colitis shows Paneth-like remodeling in the regenerative epithelium.

Conclusions:

• Secretory epithelial lineages dynamically regulate mucosal immunity and barrier integrity via region-dependent programs.
• These programs shift during chronic inflammation, impacting disease progression.
• Defining these epithelial states and signaling pathways can aid patient stratification and develop novel therapeutic approaches complementing immunomodulation.